1F6D: Toxocariasis

ICD-11 code 1F6D represents the medical condition known as Toxocariasis. This parasitic infection is caused by roundworms commonly found in cats and dogs. Humans can become infected by accidentally ingesting the eggs of these parasites through contact with contaminated soil or by consuming undercooked meat.

Toxocariasis typically presents with mild symptoms such as fever, cough, and abdominal pain. In severe cases, the infection can lead to more serious complications, including inflammation of the liver, lungs, or central nervous system. Children are particularly at risk for developing severe forms of the disease due to their tendency to play in contaminated soil and put their hands in their mouths.

Diagnosis of Toxocariasis is usually based on a combination of clinical symptoms, history of exposure, and laboratory tests to detect antibodies against the parasite. Treatment often involves antiparasitic medications to kill the worms and alleviate symptoms. Prevention of Toxocariasis includes practicing good hygiene, avoiding contact with animal feces, and deworming pets regularly.

Table of Contents:

#️⃣  Coding Considerations

The SNOMED CT code equivalent to the ICD-11 code 1F6D for Toxocariasis is 419620001. SNOMED CT, short for Systematized Nomenclature of Medicine Clinical Terms, is a comprehensive clinical terminology used by healthcare professionals worldwide. This code provides a standardized way to classify and retrieve information related to clinical procedures, diagnoses, and observations. By using this code, healthcare providers can accurately document and share information about conditions such as Toxocariasis, an infection caused by the larvae of the parasitic roundworm Toxocara canis or Toxocara cati. This standardized coding system facilitates interoperability between different healthcare systems and allows for improved communication and data sharing among healthcare providers and organizations.

In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.

The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.

🔎  Symptoms

Toxocariasis, caused by the roundworms Toxocara canis and Toxocara cati, commonly found in dogs and cats, respectively, manifests with a wide range of symptoms in humans. The severity of symptoms can vary based on the number of larvae ingested and the individual’s immune response. Common symptoms of toxocariasis include fever, coughing, wheezing, abdominal pain, and generalized weakness. In more severe cases, individuals may experience liver inflammation, vision disturbances, and neurological symptoms.

One of the hallmark symptoms of toxocariasis is eosinophilia, an increase in the number of eosinophils in the blood, which is often a sign of parasitic infections. This immune response occurs as the body tries to fight off the larvae that have migrated to various tissues. Another common symptom of toxocariasis is the formation of granulomas, which are small, localized areas of inflammation where the larvae have burrowed into tissues. These granulomas can lead to organ damage and dysfunction if left untreated.

In some cases, toxocariasis can present with more specific symptoms depending on the location of larval migration. For example, ocular toxocariasis occurs when larvae migrate to the eye, leading to symptoms such as blurred vision, floaters, and eye pain. Visceral toxocariasis occurs when larvae migrate to internal organs like the liver, lungs, or brain, leading to symptoms specific to organ dysfunction. Prompt diagnosis and treatment are essential to alleviate symptoms and prevent long-term complications of toxocariasis.

🩺  Diagnosis

Diagnosis of 1F6D (Toxocariasis) typically involves a combination of clinical evaluation, medical history, and laboratory tests. The symptoms associated with toxocariasis are often non-specific and can mimic other conditions, making diagnosis challenging. A history of contact with soil or animals, particularly dogs or cats, may raise suspicion for toxocariasis.

Blood tests such as enzyme-linked immunosorbent assay (ELISA) for specific antibodies to Toxocara canis or Toxocara cati may be utilized to confirm a diagnosis of toxocariasis. These tests can detect the presence of antibodies produced by the host’s immune response to the parasite. However, false negatives can occur early in the infection or in immunocompromised individuals.

Imaging studies such as ultrasound, computed tomography (CT), or magnetic resonance imaging (MRI) may be used to detect any abnormalities or lesions caused by migrating larvae of Toxocara species in various organs such as the liver, lungs, or eyes. These imaging studies can help in determining the extent of organ involvement and guiding treatment decisions. Additionally, biopsy of affected tissues may be performed to visualize the presence of larvae under a microscope, providing a definitive diagnosis of toxocariasis.

💊  Treatment & Recovery

Treatment and recovery methods for Toxocariasis, also known as 1F6D, typically involve the use of anthelmintic medications such as albendazole or mebendazole. These medications are effective in killing the parasites that cause the infection and are usually prescribed for a period of one to two weeks. In some cases, corticosteroids may also be prescribed to help reduce inflammation and alleviate symptoms such as swelling and pain.

Alongside medication, supportive care may also be recommended to help manage symptoms and aid in recovery. This may include rest, hydration, and pain relief medications as needed. Additionally, in severe cases where there is significant organ damage or complications, further medical interventions such as surgery may be necessary to address the issues and promote healing.

After completing the prescribed course of treatment, it is important for patients to follow up with their healthcare provider for monitoring and evaluation of their recovery progress. Regular check-ups and follow-up testing may be recommended to ensure that the infection has been fully cleared and that there are no lingering complications. It is also important for patients to maintain good hygiene practices, including regular handwashing and proper disposal of pet waste, to prevent reinfection.

🌎  Prevalence & Risk

Toxocariasis, caused by the larvae of the roundworms Toxocara canis and Toxocara cati, is a parasitic disease that primarily affects humans through ingestion of contaminated soil or food. In the United States, toxocariasis is considered relatively common, with an estimated prevalence of 13.9% in the general population. This prevalence is attributed to the widespread distribution of Toxocara-infected dogs and cats in the country.

In Europe, the prevalence of Toxocara infection varies among countries, with higher rates reported in regions with poor socioeconomic conditions and high numbers of stray animals. Studies have shown a prevalence ranging from 2% to 37% in Europe, with the highest rates found in Eastern European countries. The risk of toxocariasis in Europe is further exacerbated by inadequate sanitation and hygiene practices in certain regions.

In Asia, toxocariasis is also a significant public health concern, particularly in countries with high population densities and limited access to healthcare services. Prevalence rates in Asia vary widely depending on the level of urbanization and poverty, with studies reporting rates anywhere from 2% to 65%. Poor waste management practices, lack of awareness about the disease, and high rates of stray animals contribute to the high prevalence of toxocariasis in many Asian countries.

In Africa, despite limited data on the prevalence of toxocariasis, the disease is believed to be underdiagnosed and underreported due to poor surveillance systems and limited access to diagnostic tools. Studies in certain regions of Africa have reported prevalence rates as high as 21%, indicating that toxocariasis is a significant public health issue in the continent. The presence of stray animals and lack of awareness about the disease contribute to the high prevalence of toxocariasis in Africa.

😷  Prevention

To prevent Toxocariasis, it is essential to practice good personal and pet hygiene. It is important to wash hands thoroughly with soap and water after handling soil, pets, or potentially contaminated objects. Additionally, it is crucial to ensure that pets are regularly dewormed and their feces are properly disposed of to reduce the risk of contamination with Toxocara eggs.

Children should be closely supervised while playing outdoors to prevent accidental ingestion of contaminated soil. Encouraging children to avoid putting their hands or objects in their mouth while playing can also help reduce the risk of infection. Pet owners should also avoid allowing pets to defecate in outdoor play areas or gardens where children may come into contact with contaminated soil.

Regular visits to the veterinarian for deworming and parasite prevention can help reduce the risk of Toxocariasis in pets and minimize the shedding of Toxocara eggs in the environment. It is important to follow the veterinarian’s recommendations for parasite control and to properly dispose of pet waste in sealed bags to prevent contamination of soil and outdoor areas. Following these preventative measures can help reduce the transmission of Toxocariasis and protect both humans and animals from the infection.

Toxoplasmosis (B58.1) is a disease caused by the parasite Toxoplasma gondii. This parasite can infect humans through contact with cat feces or consuming undercooked contaminated meat. Symptoms of toxoplasmosis can range from mild flu-like symptoms to severe complications in individuals with weakened immune systems.

Echinococcosis (B67) is a disease caused by infection with tapeworm larvae of the Echinococcus species. Humans can become infected by ingesting parasite eggs through contaminated soil, food, or water. Echinococcosis can lead to the formation of cysts in various organs, causing symptoms such as abdominal pain, jaundice, and respiratory issues.

Trichinellosis (B75) is a disease caused by the roundworm Trichinella spiralis. Humans can contract trichinellosis by consuming raw or undercooked meat containing the parasite larvae. Symptoms of trichinellosis can include muscle pain, fever, facial swelling, and gastrointestinal issues.

Visceral Larva Migrans (B83.0) is a condition that occurs when parasitic larvae migrate through the body’s tissues, causing inflammation and damage. Toxocara canis and Toxocara cati, roundworms found in the intestines of dogs and cats, can cause visceral larva migrans in humans. Symptoms can include fever, cough, abdominal pain, and neurological complications.

You cannot copy content of this page